NIH-funded research R01 grant

Noninvasive nanoparticle therapy for the peripheral nervous system

Official title: Noninvasive nanoparticle-directed therapy to the peripheral nervous system

Funded at Clemson University · NIH-11550114 · Data updated 2026-11-12

Aimed at improving delivery of non-invasive treatments to injured nerves, this grant funds equipment to study how nanoparticles can cross the blood-nerve barrier and support nerve repair.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionClemson University
NIH-funded
Lab location1 site (Clemson, United States)
Project startJuly 4, 2025
Project endMarch 31, 2030
Funding year2026
Award (this year)$26,459
NIH project number3R01NS142877-02S1
Project IDNIH-11550114 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with acute or chronic peripheral nerve injuries or diseases affecting dorsal root ganglia and nerve repair processes.

Less likely to help

Patients without peripheral nerve injuries likely would not directly benefit from this basic mechanistic work.

What this research studies

This project focuses on understanding how to deliver treatments to damaged nerves without surgery. It will provide equipment to rapidly isolate and culture injured dorsal root ganglia and blood-nerve barrier cells, improving the quality of laboratory models. By enabling closer, faster analysis of nanoparticle delivery in these cells, researchers hope to uncover mechanisms that could lead to better non-invasive therapies for nerve injuries.

Why it matters

Potential benefit: If successful, it could accelerate the development of non-invasive treatments that improve nerve healing and reduce chronic pain.

How similar studies have gone: Prior work shows that understanding the blood-nerve barrier can improve drug delivery to nerves; this study builds on those methods with improved tissue culture and analysis.

Where this research is happening

  • Clemson University
    Clemson, United States
    Active

Researchers

  • Principal investigator: Larsen, Jessica — Clemson University
  • Study coordinator: Larsen, Jessica

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.